FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to endocrinology, and deals with the treatment of obesity and accompanying metabolic disorders. For this purpose a medication, which contains an activated-potentiated form of antibodies to a human cannabinoid receptor type I, is introduced.
EFFECT: method makes it possible to provide effective weight reduction and correction of metabolic disorders with the absence of side effects.
6 cl, 7 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING OBESITY AND ASSOCIATED METABOLIC DISORDERS | 2013 |
|
RU2582393C2 |
| METHOD OF INFLUENCING FUNCTIONAL ACTIVITY OF CANNABINOID RECEPTOR | 2013 |
|
RU2557971C2 |
| MEDICATION BASED ON SUBSTANCE INFLUENCING ENDOCANNABINOID SYSTEM | 2013 |
|
RU2568896C2 |
| METHOD OF TREATING PATHOLOGICAL SYNDROME AND DRUG OF CENTRAL AND PERIPHERAL ACTION FOR TREATING PATHOLOGICAL SYNDROME | 2011 |
|
RU2610438C2 |
| METHOD OF TREATING CHRONIC CARDIAC FAILURE AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC CARDIAC FAILURE | 2011 |
|
RU2523451C2 |
| DRUG PREPARATION FOR TREATING INFECTIOUS DISEASES ACCOMPANIED BY NEUROTOXIC DISORDERS, AND METHOD OF TREATING INFECTIOUS DISEASES ACCOMPANIED BY NEUROTOXIC DISORDERS | 2010 |
|
RU2446821C2 |
| DRUG PREPARATION FOR TREATING INFECTIOUS DISEASES ACCOMPANIED BY NEUROTOXIC DISORDERS, AND METHOD OF TREATING INFECTIOUS DISEASES ACCOMPANIED BY NEUROTOXIC DISORDERS | 2010 |
|
RU2522499C2 |
| THERAPEUTIC AGENT FOR TREATING INFECTIOUS DISEASES | 2014 |
|
RU2595807C2 |
| MEDICINE FOR BIRD INFLUENZA TREATMENT | 2007 |
|
RU2332236C1 |
| THERAPEUTIC AGENT FOR TREATING NEUROLOGICAL BEHAVIOUR DISORDERS AND METHOD OF TREATING NEUROLOGICAL BEHAVIOUR DEVELOPMENT DISORDERS | 2011 |
|
RU2536230C2 |
